Visit us at Booth #224
Chimerix is excited to announce that we will be on site at the upcoming SNO 2024 Annual Conference in Houston, Texas. We warmly welcome you to visit our booth #224 and meet our team.
If you are interested in meeting with the Chimerix team, please feel free to reach out to us at [email protected] to coordinate an in-person meeting.
We look forward to connecting with you and answering any questions you may have about our programs.
Chimerix Sponsored
Response by RANO2.0 criteria in ONC201 (dordaviprone)-treated patients with recurrent H3 K27M-mutant diffuse midline glioma
Abstract Number: CTNI-54
Date and Time: November 22, 2024 from 7:30 p.m. – 9:30 p.m. CT
Presenter: Timothy Cloughesy
Allosteric mitochondrial ClpP agonist ONC206 alters stress response, metabolic and epigenetic profiles to elicit anti-cancer efficacy in high-grade gliomas
Abstract Number: EXTH-37
Date and Time: November 22, 2024 from 7:30 p.m. – 9:30 p.m. CT
Presenter: Varun V. Prabhu
Safety of ONC201 treatment in patients with previously treated H3 K27M-mutant glioma: results from ONC028, an ongoing compassionate use program
Abstract Number: NCOG-07
Date and Time: November 23, 2024 from 5:00 p.m. – 5:05 p.m. CT
Presenter: Akanksha Sharma